TA322116
antibody from OriGene
Targeting: BPIFB1
bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP
Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- TA322116 - Provider product page
- Provider
- OriGene
- Product name
- Anti-BPIFB1 Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide corresponding to a region derived from 140-153 amino acids of Human BPI fold containing family B, member 1
- Description
- Anti-BPIFB1 Rabbit Polyclonal Antibody
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 1mg/ml
No comments: Submit comment
Supportive validation
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Predicted band size: 53 kDa . Positive control: Human tongue and laryngocarcinoma tissue lysate. Recommended dilution: 1/500-2000. (Gel: 10%SDS-PAGE Lane1: Human tongue tissue lysate Lane2: Human laryngocarcinoma tissue lysate Lysates: 50 ug per lane Primary antibody: 1/500 dilution Secondary antibody: Goat anti Rabbit IgG - H&L (HRP) at 1/10000 dilution Exposure time: 1 minute)
- Validation comment
- WB
Supportive validation
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Predicted cell location: Cytoplasm, Nucleus. Positive control: Human breast cancer tissue. Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded Human breast cancer tissue using BPIFB1 antibody at dilution 1/25, on the right is treated with the synthetic peptide. (Original magnification:x200)
- Validation comment
- IHC